What is AMGN(Amgen) average time for price targets to be met?

On average it took 572.57 days on average for the stock forecasts to be realized with a an average price target met ratio 87.67.

AMGN - Amgen Stock - Displayed [510 Analyst Price Targets]

AMGN - Amgen - Stock Forecast

Healthcare - Sector

Coverage Profile Stock analysts Price Targets & Ratings Chart Insider Trading

AMGN is currently covered by 25 analysts with an average price target of $313.2. This is a potential upside of $32.36 (11.52%) from yesterday's end of day stock price of $280.84.

Amgen's activity chart (see below) currently has 510 price targets and 470 ratings on display. The stock rating distribution of AMGN is 37.63% HOLD, 52.69% BUY and 9.68% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 87.67% with an average time for these price targets to be met of 572.57 days.

Highest price target for AMGN is $380, Lowest price target is $215, average price target is $308.14.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 09-Apr-2025.

What is Amgen?

Amgen is a biotechnology company that specializes in developing, manufacturing, and delivering human therapeutics.

The company’s research focuses on six main therapeutic areas, which include inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.

Products

Amgen produces drugs such as Enbrel, Neulasta, Prolia, Xgeva, Aranesp, KYPROLIS, and Repatha, which treat anemia, cardiovascular disease, multiple myeloma, osteoporosis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis.

Enbrel
- Treats inflammatory conditions such as plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis. A healthcare provider or the patient injects Enbrel to inhibit tumor necrosis factor (TNF).
Neulasta
- This product reduces the risk of infection in cancer patients undergoing chemotherapy, by stimulating the bone marrow to produce more white blood cells. It is administered by injection, usually 24 hours after chemotherapy.
Prolia
- Treats postmenopausal women with osteoporosis by inhibiting RANKL, a protein involved in bone tissue breakdown. It is given by injection every six months. Prolia can increase bone density and reduce fractures.

History

Amgen was founded in 1980 and is headquartered in Thousand Oaks, California.

Amgen in the News

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Amgen (AMGN) has recently been on Zacks.com’s list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock’s performance in the near future. Shares of this world’s largest biotech drugmaker have returned -11.5% over the past month versus the Zacks S&P 500 composite’s -12.2%...